Compare Regeneron Pharmaceuticals Inc (REGN) vs iShares Semiconductor ETF (SOXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Regeneron Pharmaceuticals Inc vs iShares Semiconductor ETF — how do they compare? Regeneron Pharmaceuticals Inc trades at $652.76 (market cap $70.79B), while iShares Semiconductor ETF trades at $554.81. The key difference: Regeneron Pharmaceuticals Inc pays a 0.56% dividend while iShares Semiconductor ETF pays none, and iShares Semiconductor ETF is trading nearer its 52-week high, Regeneron Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| REGN | SOXX | |
|---|---|---|
Market Cap | $70.79B | — |
Sector | Health | Sector/Thematic |
52-Week High | $812.27 | $655.01 |
52-Week Low | $545.46 | $236.93 |
Enterprise Value | $64.74B | — |
Dividend Yield | 0.56% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Regeneron Pharmaceuticals (REGN) trades at $675.19, down 0.22% on the day, with a bullish technical signal from moving averages. The company shows strong fundamentals with a P/E of 16.41, net income margin of 29.65%, and consistent earnings beats in recent quarters. However, sentiment is clouded by a securities class action lawsuit related to a Phase 3 clinical trial failure disclosed in July 2026.
The outlook remains positive based on analyst consensus with a $764.50 price target and 69% buy ratings, but near-term volatility is likely due to legal overhangs. Investment opportunity lies in robust profitability and growth prospects, while key risks include litigation outcomes and clinical trial setbacks.
SOXX trades at $524.14, up 0.45% with a bearish technical signal from moving averages. The semiconductor ETF faces volatility amid AI sector rotation, with RSI levels below 30 suggesting potential oversold conditions. Recent news highlights semiconductor leadership in market rebounds but also bear market concerns, with the ETF down 20% from June highs. Support levels cluster around $518-$512, while resistance begins at $529.
Outlook remains cautious due to sector concentration risks and cyclical pressures, though oversold technicals may offer near-term bounce potential. Key risks include AI trade volatility, China export controls, and hyperscaler capex pressures. Analyst views are mixed, with some highlighting long-term growth prospects despite recent underperformance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →About iShares Semiconductor ETF
SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →
